Varian News

Varian Medical Systems has received 510 clearance from the U.S. Food and Drug Administration for its diagnostic x-ray image processing workstation, which combines radio frequency and digital radiography capabilities on one platform.

Columbia University has signed a licensing agreement with Varian Medical Systems for novel imaging software that facilitates 3D segmentation, the process by which anatomical structures in medical images are distinguished from one another-an important step in the precise planning of cancer surgery and radiation treatments.

Our midyear review, we're going to talk about the first 2 quarters of fiscal year '13. I'm Elisha Finney, the Chief Financial Officer.

To enable their helpdesk associates to remotely audit devices and application as well as to have direct access hospital workstations for quickly diagnosing fixing the problems, Varian Medical Systems, a manufacturer of medical devices and software for diagnosing cancer and other medical conditions, has provisioned a new helpdesk customer service ... (more)

Pune has surpassed Bangalore as a hub for high-end engineering design and product development work done out of MNC firms' R&D outposts.

SmartConnect Bridge gives Varian's helpdesk staff direct access to hospital workstations, allowing them to remotely audit devices and applications, quickly diagnosis issues, and fix problems without having to send a technician to the site.

's stock had its "neutral" rating reaffirmed by Zacks in a research note issued on Monday, Analyst Ratings Network.com reports.

's stock had its "neutral" rating reaffirmed by Goldman Sachs in a research note issued on Thursday, Analyst Ratings Network reports.

Background Respiration-gated radiotherapy can decrease treatment toxicity by allowing for smaller treatment volumes for mobile tumors.

The firm currently has a "hold" rating on the stock. VAR has been the subject of a number of other recent research reports.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! PALO ALTO, Calif., April 24, 2013 -- /PRNewswire/ -- Varian Medical Systems today is reporting net earnings of $1.02 per diluted share in the second quarter of fiscal year 2013, up 9 percent from $0.94 in the year-ago quarter.

More than 800 oncology professionals at European Society for Radiotherapy and Oncology forum hear of pioneering treatment delivery, motion management and tumor-tracking technologies for tackling the growing lung cancer burden Cancer experts have reported future trends and progress in radiotherapy treatments for lung cancer using motion management ... (more)